Evidence map›Paper›PMID 35919520›Full record

Observational studyKidney3602022

Hypernatremia in Hospitalized Patients: A Large Population-Based Study.

Soraya Arzhan, Maria-Eleni Roumelioti, Igor Litvinovich, Cristian G Bologa, Orrin B Myers, Mark L Unruh

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in Kidney360, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Copeptin kinetics in healthy aging.The Journal of clinical endocrinology and metabolism · 2026
    Trial
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Soraya ArzhanDivision of Nephrology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico.ORCID 0000-0003-2480-0961
Maria-Eleni RoumeliotiDivision of Nephrology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico.
Igor LitvinovichDivision of Nephrology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico.
Cristian G BologaDivision of Translational Informatics, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico.ORCID 0000-0003-2232-4244
Orrin B MyersDepartment of Family and Community Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico.ORCID 0000-0002-6291-2027
Mark L UnruhDivision of Nephrology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico.
University of New Mexico · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hypernatremia is a frequently encountered electrolyte disorder in hospitalized patients. Controversies still exist over the relationship between hypernatremia and its outcomes in hospitalized patients. This study examines the relationship of hypernatremia to outcomes among hospitalized patients and the extent to which this relationship varies by kidney function and age. Methods: We conducted an observational study to investigate the association between hypernatremia, eGFR, and age at hospital admission and in-hospital mortality, and discharge dispositions. We analyzed the data of 1.9 million patients extracted from the Cerner Health Facts databases (2000-2018). Adjusted multinomial regression models were used to estimate the relationship of hypernatremia to outcomes of hospitalized patients. Results: Of all hospitalized patients, 3% had serum sodium (Na) >145 mEq/L at hospital admission. Incidence of in-hospital mortality was 12% and 2% in hyper- and normonatremic patients, respectively. The risk of all outcomes increased significantly for Na >155 mEq/L compared with the reference interval of Na=135-145 mEq/L. Odds ratios (95% confidence intervals) for in-hospital mortality and discharge to a hospice or nursing facility were 34.41 (30.59-38.71), 21.14 (17.53-25.5), and 12.21 (10.95-13.61), respectively (all Conclusions: Hypernatremia was significantly associated with in-hospital mortality and discharge to a hospice or nursing facility. The risk of in-hospital mortality and other outcomes was highest among those with Na >155 mEq/L. This work demonstrates that hypernatremia is an important factor related to discharge disposition and supports the need to study whether protocolized treatment of hypernatremia improves outcomes.

Indexed as

HypernatremiaHospitalizationHospital MortalityHumansPatient DischargeSodiumSodiumchronic kidney diseasehypernatremiamortalityoutcomes

Identifiers

PMID35919520
PMCPMC9337903
OpenAlexW4280512137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.